SEARCH

SEARCH BY CITATION

References

  • 1
    Bannasch P, Schacht U, Storch E. Morphogenese und Mikromorphologie epithelialer Nierentumoren bei Nitrosomorpholin-vergifteten Ratten. I. Induktion und Histologie der Tumouren. Z. Krebsforsch. 1974; 81: 31131.
  • 2
    Thoenes W, Storkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1985; 48: 20717.
  • 3
    Thoenes W, Störkel S, Rumpelt HJ et al. Chromophobe cell renal carcinoma and its variants: a report on 32 cases. J. Pathol. 1988; 155: 27787.
  • 4
    Cindolo L, De La Taille A, Schips L et al. Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database. Urology 2005; 654: 6816.
  • 5
    Akhtar M, Kardar H, Linjawi T et al. Chromophobe cell carcinoma of the kidney, a clinicopathological study of 21 cases. Am. J. Surg. Pathol. 1995; 19: 124556.
  • 6
    Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological feature of 50 cases. J. Urol. 1995; 154: 9647.
  • 7
    Zini L, Leroy X, Lemaitre L et al. Tumour necrosis in chromophobe renal cell carcinoma: clinical data to distinguish aggressive variants. Eur. J. Surg. Oncol. 2007; 34: 68791.
  • 8
    Jinzaki M, Tanimoto A, Mukai M et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J. Comput. Assist. Tomogr. 2000; 24: 83542.
  • 9
    Prasad SR, Narra VR, Shah R et al. Segmental disorders of the nephron: histological and imaging perspective. Br. J. Radiol. 2007; 80: 593602.
  • 10
    Störkel S, Martignoni G, Van Der Berg E. Chromophobe Renal Cell Carcinoma, in World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2004; 302.
  • 11
    Cheville JC, Lohse CM, Zincke H et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 2003; 27: 61224.
  • 12
    Kovacs G, Soudah B, Hoene E. Binucleated cells in a human renal cell carcinoma with 34 chromosomes. Cancer Genet. Cytogenet. 1988; 31: 21115.
  • 13
    Wiatrowska BA, Zakowski MF. Fine-needle aspiration biopsy of chromophobe renal cell carcinoma and oncocytoma comparison of cytomorphologic features. Cancer 1999; 87: 1617.
  • 14
    Okoń K. Pathology of renal tumours in adults. Molecular biology, histopathological diagnosis and prognosis. Pol. J. Pathol. 2008; 59: 12976.
  • 15
    Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. Am. J. Clin. Pathol. 1998; 1106: 7827.
  • 16
    Moreno SM, Banitez IA, Martinez MA et al. Ultrastructural studies in a series of 18 cases of chromophobe renal cell carcinoma. Ultrastruct. Pathol. 2005; 29: 37787.
  • 17
    Thoenes W, Baum HP, Storkel S et al. Cytoplasmic microvesicles in chromophobe cell renal carcinoma demonstrated by freeze fracture. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1987; 54: 12730.
  • 18
    Storkel S, Steart PV, Drenckhahn D et al. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch. B Cell Pathol. 1989; 56: 23745.
  • 19
    Krishnan B, Troung LD. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum. Pathol. 2002; 33: 6879.
  • 20
    Bonsib SM. Renal chromophobe carcinoma: the relationship between cytoplasmic vesicles and colloidal iron stain. J. Urol. Pathol. 1996; 4: 914.
  • 21
    Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am. J. Surg. Pathol. 1998; 22: 41924.
  • 22
    Cochand-Priollet B, Molinie V, Bougaran J et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch. Pathol. Lab. Med. 1997; 121: 10816.
  • 23
    Skinnider BF, Jones EC. Renal oncocytoma and chromophobe renal cell carcinoma: a comparison of colloidal iron staining and electron microscopy. Am. J. Clin. Pathol. 1999; 111: 796803.
  • 24
    Akhtar M, Al-Sohaibani MO, Haleem A et al. Flow cytometric DNA analysis of chromophobe cell carcinoma of the kidney. J. Urol. Pathol. 1996; 4: 1523.
  • 25
    Holzmann K, Blin N, Welter C et al. Telomeric associations and loss of telomeric DNA repeats in renal tumours. Genes Chromosomes Cancer 1993; 6: 17881.
  • 26
    Müller M, Heicappell R, Krause H et al. Telomerase activity in malignant and benign renal tumours. Eur. Urol. 1999; 35: 24955.
  • 27
    Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer 1992; 4: 2678.
  • 28
    Speicher MR, Schoell B, Du Manoir S et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am. J. Pathol. 1994; 145: 35664.
  • 29
    Bugert P, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am. J. Pathol. 1996; 149: 20818.
  • 30
    Bugert P, Gaul C, Weber K et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab. Invest. 1997; 76: 2038.
  • 31
    Herbers J, Schullerus D, Chudek J et al. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas. J. Pathol. 1998; 184: 5862.
  • 32
    Shuin T, Kondo K, Sakai N et al. A case of chromophobe renal cell carcinoma associated with low chromosome number and microsatellite instability. Cancer Genet. Cytogenet. 1996; 86: 6971.
  • 33
    Iqbal MA, Akhtar M, Ali MA. Cytogenetic findings in renal cell carcinoma. Hum. Pathol. 1996; 27: 94954.
  • 34
    Iqbal MA, Akhtar M, Ulmer C et al. FISH analysis in chromophobe renal-cell carcinoma. Diagn. Cytopathol. 2000; 22: 36.
  • 35
    Brunelli M, Eble JN, Zhang S et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod. Pathol. 2005; 18: 1619.
  • 36
    Wilhelm M, Veltman JA, Olshen A et al. Array based CGH for the differential diagnosis of renal cell cancer. Cancer Res. 2002; 62: 95760.
  • 37
    Akhtar M, Chantziantoniou N. Flow cytometric and quantitative image cell analysis of DNA ploidy in renal chromophobe cell carcinoma. Hum. Pathol. 1998; 29: 11818.
  • 38
    Monzon FA, Hagenkord JM, Lyons-Weiler MA et al. Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. Mod. Pathol. 2008; 21: 599608.
  • 39
    Hagenkord JM, Parwani AV, Lyons-Weiler MA et al. Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors. Diagn. Pathol. 2008; 3: 44.
  • 40
    Yusenko MV, Kuiper RP, Boethe T et al. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinoma and renal oncocytomas. BMC Cancer 2009; 9: 152.
  • 41
    Contractor H, Zariwala M, Bugert P et al. Mutation of the p53 tumour suppressor gene occurs preferentially in chromophobe type of renal cell tumours. J. Pathol. 1997; 181: 1369.
  • 42
    Sükösd F, Digon B, Fischer J et al. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma. Cancer Genet. Cytogenet. 2001; 128: 1613.
  • 43
    Pavlovich CP, Walther MM, Eyler RA et al. Renal tumours in Birt-Hogg-Dube syndrome. Am. J. Surg. Pathol. 2002; 26: 154252.
  • 44
    Nagy A, Zubakov D, Stupar Z et al. Lack of mutation of the folliculin gene in sporadic chromophobe RCC and renal oncocytoma. Int. J. Cancer 2004; 109: 4725.
  • 45
    Kovacs A, Störkel S, Thoenes W et al. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J. Pathol. 1992; 167: 2737.
  • 46
    Nagy A, Wilhelm M, Sükösd F et al. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer 2002; 35: 25660.
  • 47
    Boer JM, Huber WK, Sultmann H et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res. 2001; 11: 186170.
  • 48
    Young AN, Amin MB, Moreno CS et al. Expression profiling of renal epithelial neoplasms: a method for tumour classification and discovery of diagnostic molecular markers. Am. J. Pathol. 2001; 585: 163951.
  • 49
    Gieseg MA, Cody T, Man MZ et al. Expression profiling of human renal carcinoma with functional taxonomic analysis. BMC Bioinformatics 2002; 3: 113.
  • 50
    Takahashi M, Yang XY, Sugimura J et al. Molecular subclassification of kidney tumours and the discovery of new diagnostic markers. Oncogene 2003; 22: 681018.
  • 51
    Higgins JPT, Shinghal R, Gill H et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am. J. Pathol. 2003; 1623: 92532.
  • 52
    Schuetz AN, Yin-Goen Q, Amin MB et al. Molecular classification of renal tumours by gene expression profiling. J. Mol. Diagn. 2005; 7: 20618.
  • 53
    Jones J, Out H, Spentzos D et al. Gene signatures of progression and metastasis in renal cell cancer. Clin. Cancer Res. 2005; 11: 57309.
  • 54
    Rohan S, Tu JJ, Kao J et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin. Cancer Res. 2006; 12: 693745.
  • 55
    Yang XJ, Sugimura J, Schafernak KT et al. Classification of renal neoplasms based on molecular signatures. J. Urol. 2006; 175: 23026.
  • 56
    Yusenko MV, Zubakov D, Kovacs G. Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours. Int. J. Biol. Sci. 2009; 5: 51727.
  • 57
    Kim SS, Choi YD, Jin XM et al. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2009; 54: 6335.
  • 58
    Furge KA, Lucas KA, Takahashi M et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res. 2004; 64: 411721.
  • 59
    Garcia E, Li M. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am. J. Clin. Pathol. 2006; 125: 3928.
  • 60
    Leroy X, Moukassa D, Copin MC et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur. Urol. 2000; 37: 4847.
  • 61
    Mathers ME, Pollock AM, Marsh C et al. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002; 40: 5637.
  • 62
    Mazal PR, Exner M, Haitel A et al. Expression of kidney specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum. Pathol. 2005; 36: 228.
  • 63
    Adley BP, Papavero V, Sugimura J et al. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal. Quant. Cytol. Histol. 2006; 28: 22836.
  • 64
    Memeo L, Jhang J, Assad AM et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am. J. Clin. Pathol. 2007; 1272: 2259.
  • 65
    Liu L, Qian J, Singh H et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch. Pathol. Lab. Med. 2007; 1318: 12907.
  • 66
    Choi YD, Kim KS, Ryu S et al. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. J. Korean Med. Sci. 2007; 222: 30510.
  • 67
    Hornsby CD, Cohen C, Amin MB et al. Claudin-7 immunohistochemistry in renal tumours: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Arch. Pathol. Lab. Med. 2007; 131: 15416.
  • 68
    Osunkoya AO, Cohen C, Lawson D et al. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum. Pathol. 2009; 40: 20610.
  • 69
    Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am. J. Clin. Pathol. 2004; 121: 87883.
  • 70
    Went P, Dirnhofer S, Salvisberg T et al. Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumours. Am. J. Surg. Pathol. 2005; 29: 838.
  • 71
    Khoury JD, Abrahams NA, Levin HS et al. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann. Diagn. Pathol. 2002; 6: 1548.
  • 72
    Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000; 24: 20310.
  • 73
    Lin BT, Brynes RK, Gelb AB et al. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study. Mod. Pathol. 1998; 11: 107581.
  • 74
    Lin F, Yang W, Betten M et al. Expression of S-100 protein in renal cell neoplasms. Hum. Pathol. 2006; 37: 46270.
  • 75
    Li G, Barthelemy A, Feng G et al. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2007; 50: 6427.
  • 76
    Rocca PC, Brunelli M, Gobbo S et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod. Pathol. 2007; 20: 7228.
  • 77
    Kauffman EC, Barocas DA, Chen YT et al. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. J. Urol. 2009; 181: 230511.
  • 78
    Yusenko MV, Kovacs G. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Histopathology 2009; 55: 68795.
  • 79
    Klatte T, Han KR, Said JW et al. Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol. Oncol. 2008; 6: 6049.
  • 80
    Amin MB, Tamboli P, Javidan J et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 2002; 26: 28191.
  • 81
    Renshaw AA, Henske EP, Loughlin KR et al. Aggressive variants of chromophobe renal cell carcinoma. Cancer 1996; 78: 175661.
  • 82
    Motzer RJ, Bacik J, Mariani T et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J. Clin. Oncol. 2002; 20: 237681.
  • 83
    Akhtar M, Kfoury H, Linjawi T et al. Sarcomatoid chromophobe cell carcinoma of the kidney. J. Urol. Pathol. 1996; 4: 15566.
  • 84
    Renshaw AA, Richie JP. Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. Am. J. Clin. Pathol. 1999; 111: 53943.
  • 85
    Badoual C, Tissier F, Lagorce-Pages C et al. Pulmonary metastases from a chromophobe renal cell carcinoma: 10 years' evolution. Histopathology 2002; 40: 3002.
  • 86
    Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982; 6: 65563.
  • 87
    De Peralta-Venturina M, Moch H, Amin M et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am. J. Surg. Pathol. 2001; 25: 27584.
  • 88
    Brunelli M, Gobbo S, Cossu-Rocca P et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod. Pathol. 2007; 20: 3039.